Vinson & Elkins LLP advised Orchid Island Capital on the deal. Orchid Island Capital, Inc. (the “Company”) in its underwritten public offering of 8,740,000 shares of...
Orchid Island Capital’s $45.3 Million Shares Offering
Driven Brands’ $700 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Driven Brands Holdings Inc. has announced the pricing of its initial public offering of 31,818,182 shares...
Queen’s Gambit Growth Capital’s IPO
Vinson & Elkins LLP and Walkers’ Cayman advised Queen’s Gambit Growth Capital on the deal. Queen’s Gambit Growth Capital announced its initial public offering of 34,500,000 units...
Elliott Investment Management’s Investment in Removery
Ropes & Gray represented Elliott Investment Management L.P. in the transaction. Removery, the largest specialized provider of tattoo removal, change, and fade services in North America,...
Rewind’s $15 Million Financing Round
Osler, Hoskin & Harcourt LLP advised Inovia Capital on the financing. On January 19, 2021, Rewind completed its US$15 million Series A financing round led by...
Enerplus’ $465 Million Shares Acquisition Of Bruin E&P HoldCo
Vinson & Elkins LLP advised Enerplus Corporation on the deal, while Willkie represented Bruin Purchaser. Enerplus Corporation (TSX &NYSE: ERF) announced that it has entered into a...
FreeWire Technologies’ $50M Series C Funding Round
Vinson & Elkins LLP advised Riverstone Holdings on the deal. FreeWire Technologies, a San Leandro, Calif.-based provider of electric vehicle (EV) charging and power solutions, raised...
TPG Growth and The Rise Fund’s Major Investment in Greenhouse Software
Vinson & Elkins LLP advised TPG Capital Management on the deal. TPG Capital Management, L.P., through certain subsidiaries, announced the definitive agreement between TPG Growth and...
Hurdle’s $5 Million Series Seed Financing
Wilson Sonsini Goodrich & Rosati advised Hurdle on the deal. Hurdle, an innovative digital mental health platform company, announced it has successfully closed a $5 million...
Verve Therapeutics’ $94M Series B Financing
Wilmer Cutler Pickering Hale and Dorr LLP advised Verve Therapeutics on the deal. Verve Therapeutics, a biotech company pioneering gene editing medicines to treat cardiovascular disease,...
Sartorius Stedim Biotech’s Acquisition of Novasep
Jeantet and Milbank LLP advised Sartorius, while White & Case LLP advised Novasep on the deal. Novasep announced the proposed sale of its chromatography process equipment division...
Touax’ €180 Million Asset Refinancing in the Rail Division
McCann FitzGerald and Stephenson Harwoo advised Touax Rail Limited on the operation. Touax Rail Limited announced the refinancing of its Railcar division for a total of €180 million...